dr. rule on the role of btk inhibitors in mcl
Published 6 years ago • 101 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
1:13
dr. rule on the next steps for btk inhibitors in mcl
-
1:47
dr. leslie on the role of btk inhibitors in relapsed/refractory mcl
-
1:21
dr koff on the role of covalent btk inhibitors and pirtobrutinib in mcl
-
2:16
dr. ruan discusses btk inhibitors in mcl
-
1:16
dr. patel on differences between btk inhibitors in mcl
-
0:41
dr. goy on the potential utility of btk inhibitors as maintenance in mcl
-
2:29
dr. ruan on the impact of btk inhibitors in mcl
-
1:09
dr. cohen on the potential of btk inhibitors in frontline treatment of mcl
-
1:23
dr. rule on the future treatment paradigm in mcl
-
0:57
dr. rule on treatment of young, fit patients with mcl
-
0:55
dr. smith on safety profiles of btk inhibitors in mcl
-
0:59
dr. rule on the fda approval of zanubrutinib in mcl
-
5:59
differentiating btk inhibitor mechanisms of action in mcl
-
2:00
dr. goy discusses btk inhibitors in mcl
-
1:15
dr. flinn on the role of btk inhibitors in cll
-
1:10
dr. wang on the toxicity of ibrutinib, acalabrutinib, and zanubrutinib in mcl
-
4:16
mcl: differences in trial design between btk inhibitors
-
1:22
dr. rule on searching for a biomarker indicating indolent mcl
-
1:29
dr. rule on the treatment paradigm in mcl